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Abstract:  
Several indoline derivatives with specific geometries are biologically active and have inhibitor 
properties. Many indolines are a key part of natural products. Much attention has been focused on the 
development of synthetic routes for their easy access. Current synthesis depends largely on metal 
catalysis, iodine reagents and Oxone. To date, no synthetic route has been established which is metal-
, reagent-free and environmentally friendly and provides a base for green chemistry. Here we report the 
first facile metal- and reagent-free synthesis of indoline derivatives, which could potentially be influential 
in the design of new biologically active compounds. The synthesis proceeds through intramolecular 
amination between a urea nucleophile and unactivated alkene. The ring closure occurs in a few hours 
in the presence of pre-dried silica gel and gives good yields of indolines products but in the absence of 
silica gel, the ring closure occurred overnight with stirring in dry solvent. An electron withdrawing group 
(EWG) at the substituted aryl moiety of ureas increases the hydrogen bond donor ability of substrates 
that mediate the internal proton transfer at the terminal alkene and results in facile amination to give the 
indoline product with an "in plane" orientation of the carbonyl group and aromatic part of indoline 
framework. Such orientation in indolines is important for potent biological activities. 
 
Introduction 
The indoline moiety is an important component of many natural products1 pharmaceuticals2 (Fig. 1) and 
in addition, optically active indoline derivatives serve as either organocatalysts or chiral auxiliaries for 
asymmetric transformations.3 Indoline derivatives have been proven to exhibit anticancer properties4, 
tried as sensitizers of bacteria against β-lactam antibacterial agents,5 worked as promising human 
protein kinase inhibitors6, apoptosis protein inhibitors7, and monoacylglycerol acyltransferase-2 
inhibitors.8 Due to the promising role of indoline derivatives in biological activities, much attention has 
been focused on the development of synthetic routes for their easy access. The routine routes to 
synthesise this kind of nitrogen heterocycles follows the transformation through oxidative 
difunctionalization of unactivated alkenes. The famous and advance transformations are alkenes vicinal 
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difunctionalization.9 A problem with the synthesis of most indoline derivatives is the involvement of toxic 
and expensive metals.10 Although metal-free synthesis has been reported, these protocols depend on 
iodine reagents and Oxone.11 Organic methodologies involving metal-free and one-pot synthesis of 
target compounds are desirable because they tend to display perfect atom economy. Toward this goal, 
we also focus our attention on the one-pot synthesis of indoline derivatives. Herein, we report a facile 
metal-free and reagent-free in situ synthesis of indolines (4a, b) in the presence and absence of silica 
gel. Silica gel has a uniform and 3D network containing silicon oxide units. In hydrated form, silica gel 
behaves akin to silicic acid and has been used in chemical synthesis under mild conditions and gave 
high chemo-, regio- and stereoselective products without complex isolation procedures in comparison 
with homogeneous reactions. It is also a simple reaction catalysing agent in cyclisation reactions.12 
The mainframe of the structure of the indoline derivatives (4) under investigation is similar to 
those in anticancer agents and natural products (see Fig.1), and thus the synthesis could be influential 
in designing complex indoline- based structures with good biologically activities. In 1990, King et al.4a 
reported 5-hydroxytryptamine (5-HT3) receptor antagonists that showed that aromaticity in the 5-
membered ring of the bicyclic aromatic nucleus is not necessary for potency. Instead, an "in plane" 
orientation of the carbonyl group is important. They argued that the 5-membered indoline ring acts as 
a spacer to maintain orientation of the carbonyl linkage and the monocyclic aromatic system. Taking 
into consideration the points highlighted by King et al. we introduced an additional substituted aromatic 
ring on opposite side of the indoline framework which could help to enhance biological activity. 
Indapamide (see Fig.1) has the same mainframe as 4a, b and is use as drug for the treatment of 
hypertension and decompensate heart failure.13 Takayanagi group reported similar indoline derivatives 
which interact with muscarinic receptors. These derivative contracted guinea-pig ileum and behaved as 
antagonists.4b  
 
Figure 1. Representative compounds containing the indoline.  
Results and Discussion 
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  We have adopted a very simple one-pot synthetic approach for indoline derivatives. O-allylic 
aniline was reacted with aryl isocynates having electron-withdrawing groups, in dry CH2Cl2 under 
nitrogen atmosphere and stirred in the presence and absence of silica gel to give a single indoline 
product 4 in high yield (Scheme 1). Initially conditions were optimized by using precursors O-allylic 
aniline 1 and 4-(Trifluoromethyl)phenyl isocyanate 2a for successful transformation to indoline 
derivative 4a. The reaction was monitored on thin-layer chromatography (TLC). In the first two hours, 
urea formation (3a) was complete, and then the reaction was stirred for four hours in the presence of 
silica gel at room temperature to fully convert the urea moiety to the indoline derivative 4a.  
 
 
Scheme 1. Synthesis of indoline derivatives 4 (a-d). 
 
Presumably, this reaction proceeds on the surface of silica gel that promotes cyclisation and results in 
intramolecular amination by a nucleophilic attack of the urea on terminal alkene, followed by internal 
proton transfer for the final indoline product (see Figure 2 for possible mechanism). In another 
experiment, the reaction was stirred in the absence of silica gel at room temperature to fully convert the 
urea moiety to indoline derivative 4a but the reaction was carried out overnight and the yield was low 
as compared to the reaction performed in the presence of silica gel. In the second case, the reaction 
might proceed due the presence of the electron-withdrawing group that makes the urea derivative a 
hydrogen bond donor, and the first step is intramolecular proton transfer to alkene, followed by 
nucleophilic attack of nitrogen atom.   
 
Figure 2. Possible pathway for indoline formation as a result of intramolecular amination through 
internal proton transfer from urea hydrogen bond donor to terminal end of alkene activated through 
silica gel. 
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In the third experiment, the reaction was stopped after two hours on completion of urea 
formation (3a) and the product was purified for characterization which clearly showed the urea moiety 
3a (see Supporting Information). However, during purification of 3a on the silica gel column, we also 
observed the formation of indoline 4a alongside which also shows that silica promotes cyclisation. The 
same conditions used for 4a synthesis, were applied for the synthesis of indoline derivative 4b using 
substrate 2b, again noting the electron-withdrawing nature of the aryl group, and the reaction also 
generated good yields. Cyclisation was also attempted in the presence and absence of silica gel using 
substrates 3c, d which also contain electron donating groups on the aromatic ring (see Supporting 
information for characterization data of 3c, d).  However, only minor traces of cyclic products 4c, d (R 
= -CH3, -OCH3) were observed at TLC plate. Presumably, the electron donating groups on the aryl ring 
might quench the ability of urea derivatives to act as hydrogen bond donors resulting in minor traces. 
These results show that this methodology is effective for the substrates of electron deficient nature. 
Indolines 4a and 4b were crystallized from CH3CN at room temperature and their X-ray analysis clearly 
shows the cyclisation products with an "in plane" orientation of the carbonyl group relative to the 
aromatic part of the indoline framework14 that might be essential for potent biological activities.4a In the 
indole groups, the five-membered is in half-envelope conformation (Figure 3) with atom C2 as the flap. 
The largest atomic deviations from the least-squares planes through both the indole and carbonyl 
groups are by the flap atoms (C2) at 0.190(3)Å for 4a and 0.230(2)Å for 4b. The carbonyl oxygen atoms 
are located on the opposite side of the plane.  
 
(a)                                                                                 (c) 
 
(b)                                                                              (d) 
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Figure 3. X-ray structure of indolines for (a) 4a and (b) 4b showing thermal ellipsoids at 50% 
probability. The view along the planes of the carbonyl group and indoline moieties for (c) 4a and (d) 
4b. 
Conclusion  
Indolines with specific conformation are an important part of many pharmacologically important 
compounds, natural products and represent a class of biologically active compounds. Conventional 
synthesis depends largely on metal catalysis and iodine reagents with associated toxicity and 
purification problems and there is therefore need for a metal-, reagent-free and environmentally friendly 
method to be developed. We report the first facile metal- and reagent-free synthesis of indoline 
derivatives 4a and b. The synthesis proceeds through intramolecular amination between the urea 
nucleophile and unactivated alkene. Fast ring closure occurs in the presence of pre-dried silica gel and 
gives good yields of indoline products with an "in plane" orientation of the carbonyl group relative to the 
aromatic part of the indoline framework. We anticipate that this facile synthesis of indoline derivatives, 
mediated by the hydrogen bond donor nature of ureas, can play an important role in designing more 
promising derivatives with potential for use in biological trials 
 
Experimental Section 
All the solvent and chemicals were purchased from Sigma Aldrich, Alfa Aesar, Acros Organic and 
FluoroChem and were used without further purification. The reactions were carried out under nitrogen 
atmosphere. Thin-layer chromatography (TLC) was performed on pre-coated aluminium sheets of 
Merck silica gel 60 F254 (0.20 mm) and visualised by UV radiation (254 nm). 1H NMR and 13C NMR 
spectra were measured on Bruker DPX 300, 400 or 500 apparatus. Mass spectrometric measurements 
were performed by the EPSRC Mass Spectrometry Facility in Swansea University on a Waters Xevo 
G2-S and on a Thermo Scientific LTQ Orbitrap XL machine for high-resolution mass spectroscopy 
(HRMS).  
General procedure for the preparation of Indoline derivatives 
To a stirred solution of an aryl isocyanate (1.0 equiv) in dry CH2Cl2 at 0 °C under N2, the 
corresponding allylamine (1.0 equiv) was added. The reaction was allowed to warm to room 
temperature and stirred for 4 hours in the presence of silica gel (500 mg, here is important to mention 
that more than this amount of silica gel have no effect on yield). In another experiment, the reaction 
was stirred overnight in the absence of silica gel. For the workup separately, the reaction mixture was 
then diluted with CH2Cl2, washed with water, HCl (1 N), NaHCO3 (sat.) and brine, dried with anhydrous 
MgSO4. The mixture was filtered, and the filtrate was concentrated under vacuum. The residue was 
purified through silica gel flash chromatography (eluents: hexanes and ethyl acetate). 
Synthesis of 2-allyl aniline (1) 
In a 100-mL 2-neck round bottom flask, a solution of N-allylaniline (5.0 g, 37.5 mmol) in m-
xylene (70 mL) was first cooled at −78 o C and then was added boron trifluoride etherate (5.6 mL, 45 
mmol) under inert nitrogen atmosphere. After 5 min, the solution was warmed to room temperature. 
After 15 min, heated to 180 o C. After 72 h, the reaction was cooled down to room temperature and 
quenched with 2M NaOH solution (80 mL) at 0 oC. The organic layer was separated and the aqueous 
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layer was extracted with diethyl ether (70 mL × 3). All the combined organic layers were washed with 
brine solution and then dried over anhydrous MgSO4 and then concentrated in vacuo. The residue was 
purified by flash column chromatography to give as a yellow oil, 71% yield. Pale yellow oil; 1H NMR 
(300 MHz, CDCl3) δ 7.26 – 7.14 (m, 2H), 6.89 (td, J = 7.4, 1.2 Hz, 1H), 6.78 (dd, J = 7.8, 0.9 Hz, 1H), 
6.09 (ddt, J = 16.5, 10.3, 6.2 Hz, 1H), 5.32 – 5.18 (m, 2H), 3.76 (s, 2H), 3.42 (dt, J = 6.1, 1.4 Hz, 2H); 
13C NMR (75 MHz, CDCl3) δ 145.01, 145.01, 136.11, 136.11, 130.3, 130.30, 127.69, 127.69, 124.10, 
124.10, 118.96, 118.96, 116.25, 115.95, 36.59; HRMS m/z: calcd 133.0891 g/mol. observed 134.096, 
2-methyl-N-(4-(trifluoromethyl)phenyl)indoline-1-carboxamide (4a) 
To a stirred solution of 4-(Trifluoromethyl)phenyl isocyanate (0.711g, 3.7mmol, 1.0 equiv) in dry 
CH2Cl2 (10mL) at 0 °C under N2, the o-allylamine (0.5g, 3.7mmol ,1.0 equiv) was added. The reaction 
was allowed to warm to room temperature and stirred for four hours in the presence of predried silica 
gel (500 mg). The reaction mixture was then diluted with CH2Cl2, washed with water, HCl (1 N), NaHCO3 
(sat.) and brine, dried with anhydrous MgSO4. The mixture was filtered, and the filtrate was concentrated 
under vacuum. The residue was purified through silica gel flash chromatography (eluents: hexanes and 
ethyl acetate). 84% yield. White crystalline solid, mp = 187-189°C; 1H NMR (300 MHz, Acetone) δ 8.33 
(s, 1H), 7.99 (d, J = 7.8 Hz, 1H), 7.88 (d, J = 8.5 Hz, 2H), 7.63 (d, J = 8.5 Hz, 2H), 7.27 – 7.13 (m, 2H), 
6.96 (td, J = 7.4, 1.0 Hz, 1H), 4.91 – 4.78 (m, 1H), 3.44 (dd, J = 15.9, 9.1 Hz, 1H), 2.73 (d, J = 15.9 Hz, 
1H), 1.34 (d, J = 6.3 Hz, 3H). 13C NMR (126 MHz, Acetone) δ 151.70, 143.68, 143.67, 142.51, 130.05, 
127.14, 125.67, 125.02, 122.34, 119.49, 115.83, 54.91, 35.99, 20.3; ESI HRMS m/z: calcd 320.1136 
g/mol, Observed 321.1252g/mol. 
2-methyl-N-(4-nitrophenyl)indoline-1-carboxamide (4b) 
To a stirred solution of 4-Nitrophenyl isocyanate (0.623g, 3.7mmol, 1.0 equiv) in dry CH2Cl2 
(10mL) at 0 °C under N2, the o-allylamine (0.5g, 3.7mmol, 1.0 equiv) was added. The reaction was 
allowed to warm to room temperature and stirred for four hours in the presence of predried silica gel 
(500 mg). The reaction mixture was then diluted with CH2Cl2, washed with water, HCl (1 N), NaHCO3 
(sat.) and brine, dried with anhydrous MgSO4. The mixture was filtered, and the filtrate was concentrated 
under vacuum. The residue was purified through silica gel flash chromatography (eluents: hexanes and 
ethyl acetate), 89% Yield. Yellow crystalline solid, mp = 157-159°C; 1H NMR (300 MHz, Acetone) δ 
8.58 (s, 1H), 8.29 – 8.13 (m, 2H), 7.99 (d, J = 7.7 Hz, 1H), 7.97 – 7.89 (m, 2H), 7.32 – 7.09 (m, 2H), 
6.99 (td, J = 7.4, 1.0 Hz, 1H), 4.88 (dqd, J = 11.0, 6.3, 1.8 Hz, 1H), 3.46 (dd, J = 15.9, 9.1 Hz, 1H), 2.76 
(d, J = 15.9 Hz, 1H), 1.35 (d, J = 6.3 Hz, 3H); 13C NMR (126 MHz, Acetone) δ 151.32, 146.46, 142.25, 
142.22, 130.20, 127.19, 125.08, 124.51, 122.64, 118.94, 115.98, 55.04, 35.98, 20.40; ESI HRMS m/z: 
calcd 297.1113g/mol, observed 298.1188g/mol. 
 
Crystal Structure Determination 
Single-crystal X-ray diffraction data were recorded at ambient temperature using an Agilent SuperNova 
Dual Atlas diffractometer equipped with a mirror monochromator using Mo Kα ( = 0.71073Å) radiation. 
Generally, H atoms were inserted in idealized positions and refined using a riding model, with Uiso(H) 
values equal to 1.2 or 1.5 times the Ueq value of the atom to which it is bonded and with methyl groups 
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allowed to rotate about the C-C bond. Structure solution and refinement were performed using 
SHELXS-2013 and SHEXL-2018 respectively. 
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